Spero Therapeutics (SPRO) News Today → Top 5 Tech Stocks to Buy for 2024 (From Daily Market Alerts) (Ad) Free SPRO Stock Alerts $1.40 -0.04 (-2.77%) (As of 06/7/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative June 6 at 3:59 AM | marketbeat.comSpero Therapeutics (NASDAQ:SPRO) Stock Passes Below Two Hundred Day Moving Average of $1.50Spero Therapeutics (NASDAQ:SPRO) Shares Pass Below Two Hundred Day Moving Average of $1.50June 3, 2024 | globenewswire.comSpero Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)May 28, 2024 | marketbeat.comSpero Therapeutics (NASDAQ:SPRO) Shares Pass Below Two Hundred Day Moving Average of $1.49Spero Therapeutics (NASDAQ:SPRO) Shares Pass Below 200 Day Moving Average of $1.49May 16, 2024 | finanznachrichten.deSpero Therapeutics, Inc.: Spero Therapeutics Announces First Quarter 2024 Operating Results and Provides a Business UpdateMay 16, 2024 | globenewswire.comSpero Therapeutics to Participate in H.C. Wainwright Annual BioConnect Investor ConferenceMay 16, 2024 | markets.businessinsider.comBuy Rating Affirmed for Spero Therapeutics Amidst Drug Pipeline Progress and Strategic PartnershipsMay 15, 2024 | globenewswire.comSpero Therapeutics Announces First Quarter 2024 Operating Results and Provides a Business UpdateMay 14, 2024 | msn.comSpero Therapeutics Q1 2024 Earnings PreviewMay 10, 2024 | finance.yahoo.comShareholders in Spero Therapeutics (NASDAQ:SPRO) are in the red if they invested three years agoMay 8, 2024 | globenewswire.comSpero Therapeutics to Report First Quarter 2024 Financial Results and Provide Business Update on Wednesday, May 15, 2024May 1, 2024 | globenewswire.comSpero Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)April 28, 2024 | marketbeat.comSpero Therapeutics, Inc. (NASDAQ:SPRO) Short Interest UpdateSpero Therapeutics, Inc. (NASDAQ:SPRO - Get Free Report) was the target of a large decline in short interest in April. As of April 15th, there was short interest totalling 513,200 shares, a decline of 21.5% from the March 31st total of 653,800 shares. Based on an average daily trading volume, of 321,500 shares, the short-interest ratio is presently 1.6 days.April 4, 2024 | marketbeat.comSpero Therapeutics (NASDAQ:SPRO) Rating Reiterated by Cantor FitzgeraldCantor Fitzgerald reaffirmed an "overweight" rating on shares of Spero Therapeutics in a research report on Thursday.March 20, 2024 | marketbeat.comHC Wainwright Comments on Spero Therapeutics, Inc.'s Q1 2024 Earnings (NASDAQ:SPRO)Spero Therapeutics, Inc. (NASDAQ:SPRO - Free Report) - HC Wainwright issued their Q1 2024 earnings estimates for Spero Therapeutics in a research report issued on Monday, March 18th. HC Wainwright analyst R. Selvaraju anticipates that the company will post earnings of ($0.12) per share for the quMarch 19, 2024 | marketbeat.comHC Wainwright Weighs in on Spero Therapeutics, Inc.'s FY2025 Earnings (NASDAQ:SPRO)Spero Therapeutics, Inc. (NASDAQ:SPRO - Free Report) - Analysts at HC Wainwright issued their FY2025 earnings estimates for shares of Spero Therapeutics in a research report issued to clients and investors on Monday, March 18th. HC Wainwright analyst R. Selvaraju anticipates that the company willMarch 18, 2024 | marketbeat.comSpero Therapeutics (NASDAQ:SPRO) Given Buy Rating at HC WainwrightHC Wainwright reiterated a "buy" rating and set a $7.00 target price on shares of Spero Therapeutics in a research report on Monday.March 18, 2024 | markets.businessinsider.comSpero Therapeutics’ Robust Drug Pipeline and Positive Trial Advancements Prompt Buy RatingMarch 17, 2024 | finance.yahoo.comSpero Therapeutics, Inc. Beat Analyst Estimates: See What The Consensus Is Forecasting For This YearMarch 15, 2024 | finance.yahoo.comSpero Therapeutics, Inc. (NASDAQ:SPRO) Q4 2023 Earnings Call TranscriptMarch 15, 2024 | finance.yahoo.comSpero Therapeutics, Inc.'s (NASDAQ:SPRO) Stock's On An Uptrend: Are Strong Financials Guiding The Market?March 14, 2024 | finanznachrichten.deSpero Therapeutics, Inc.: Spero Therapeutics Announces Fourth Quarter and Full Year 2023 Operating Results and Provides a Business UpdateMarch 14, 2024 | finance.yahoo.comQ4 2023 Spero Therapeutics Inc Earnings CallMarch 14, 2024 | markets.businessinsider.comTD Cowen Sticks to Its Hold Rating for Spero Therapeutics (SPRO)March 13, 2024 | benzinga.comRecap: Spero Therapeutics Q4 EarningsMarch 13, 2024 | msn.comSpero Therapeutics GAAP EPS of $0.96 beats by $1.06, revenue of $73.5M beats by $54.87MMarch 13, 2024 | globenewswire.comSpero Therapeutics Announces Fourth Quarter and Full Year 2023 Operating Results and Provides a Business UpdateMarch 12, 2024 | msn.comSpero Therapeutics Q4 2023 Earnings PreviewMarch 7, 2024 | marketbeat.comSpero Therapeutics (SPRO) to Announce Quarterly Earnings on WednesdaySpero Therapeutics (NASDAQ:SPRO) will be releasing earnings after the market closes on Wednesday, March 13, Zacks reports.March 6, 2024 | globenewswire.comSpero Therapeutics to Provide Business Update and Report Fourth Quarter and Full Year 2023 Financial Results on Wednesday, March 13, 2024February 28, 2024 | finanznachrichten.deSpero Therapeutics, Inc.: Spero Therapeutics Announces Clearance of IND for SPR206 to Treat MDR Gram-negative Bacterial InfectionsFebruary 28, 2024 | markets.businessinsider.comSpero Announces FDA Clearance Of IND Application For SPR206February 28, 2024 | finance.yahoo.comSpero Therapeutics Announces Clearance of IND for SPR206 to Treat MDR Gram-negative Bacterial InfectionsFebruary 28, 2024 | globenewswire.comSpero Therapeutics Announces Clearance of IND for SPR206 to Treat MDR Gram-negative Bacterial InfectionsFebruary 26, 2024 | finance.yahoo.comSpero Therapeutics to Present at Cowen’s 44th Annual Healthcare ConferenceFebruary 26, 2024 | globenewswire.comSpero Therapeutics to Present at Cowen's 44th Annual Healthcare ConferenceFebruary 17, 2024 | ca.finance.yahoo.comSPRO Apr 2024 1.000 callFebruary 17, 2024 | ca.finance.yahoo.comSPRO Apr 2024 2.000 putFebruary 10, 2024 | msn.comSpero Therapeutics Announces Chief Legal Officer’s ResignationFebruary 10, 2024 | marketbeat.comSpero Therapeutics (NASDAQ:SPRO) Stock Price Passes Above 200-Day Moving Average of $1.31Spero Therapeutics (NASDAQ:SPRO) Stock Price Crosses Above Two Hundred Day Moving Average of $1.31February 9, 2024 | uk.investing.comSpero Therapeutics Inc (SPRO)February 6, 2024 | finance.yahoo.comSpero Therapeutics Inc CEO Sath Shukla Sells 75,994 SharesJanuary 31, 2024 | finance.yahoo.comSpero Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)January 19, 2024 | finance.yahoo.comSpero Therapeutics, Inc. (NASDAQ:SPRO): Are Analysts Optimistic?January 5, 2024 | finanznachrichten.deSpero Therapeutics, Inc.: Spero Therapeutics Provides Corporate Update and 2024 OutlookJanuary 5, 2024 | msn.comSpero Therapeutics says cash and cash equivalents as of December 31 were about $76.3MJanuary 5, 2024 | finance.yahoo.comSpero Therapeutics Provides Corporate Update and 2024 OutlookJanuary 4, 2024 | markets.businessinsider.comSpero Therapeutics’ Promising Outlook: Clinical Milestones and Strategic GSK PartnershipJanuary 2, 2024 | finance.yahoo.comSpero Therapeutics Announces First Patient, First Visit for Phase 3 PIVOT-PO Trial Evaluating Tebipenem HBr in Complicated Urinary Tract InfectionsJanuary 2, 2024 | finance.yahoo.comSpero Therapeutics Announces First Patient, First Visit for Phase 3 PIVOT-PO Trial Evaluating Tebipenem HBr in Complicated Urinary Tract InfectionsNovember 14, 2023 | finance.yahoo.comSpero Therapeutics, Inc. (NASDAQ:SPRO) Q3 2023 Earnings Call Transcript Get Spero Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for SPRO and its competitors with MarketBeat's FREE daily newsletter. Email Address No Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for Free (Ad)Optimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analysis meets hedge fund-level market foresight! TRY "INVESTING IDEAS" TODAY SPRO Media Mentions By Week SPRO Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. SPRO News Sentiment▼0.300.73▲Average Medical News Sentiment SPRO News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. SPRO Articles This Week▼21▲SPRO Articles Average Week Get Spero Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for SPRO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Atea Pharmaceuticals News Kamada News XOMA News ADC Therapeutics News CorMedix News Mersana Therapeutics News Vanda Pharmaceuticals News Nature's Sunshine Products News Xeris Biopharma News Aquestive Therapeutics News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:SPRO) was last updated on 6/8/2024 by MarketBeat.com Staff From Our PartnersMillionaire-Making “Wealth Pattern” Just Repeated on April 22If you think you missed out on the Bitcoin band wagon… You need to watch this immediately.Paradigm Press | SponsoredBreaking - The US Gov. Seized CITGODo you want an investment that can double or triple your money in the next three months? The US Court is cu...Augury Research | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for FreeOptimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...Hedgeye | SponsoredAI Hell Will Break Loose [June 30, 2024] …On June 30, 2024, AI will reach a critical tipping point… Whatever you do, make sure you prepare before Ju...Banyan Hill Publishing | SponsoredWas the Great Financial Crisis fun?The Great Financial Crisis, which actually started in the summer of 2007 and did not end until March of 2009, ...Brooks Enterprises | SponsoredCollapse of the Petrodollar The death of the "petrodollar" seems imminent. And the implications could not be worse for Americans. Ru...Colonial Metals | Sponsored